Sign Out
Vexdo (Docetaxel Injection) is a microtubule inhibitor indicated for: Breast Cancer (BC): Single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node positive BC.
Non-Small Cell Lung Cancer (NSCLC): Single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced of metastatic untreated NSCLC.
Hormone Refractory Prostate Cancer (HRPC): With prednisone in androgen independent (Hormone Refractory) metastatic prostate cancer.
Gastric Adenocarcinoma (GC): With cisplatin and fluorouracil for untreated, advanced GC, including the gastroesophageal junction.
Squamous Cell Carcinomas of the Head and Neck Cancer (SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN.
Continue with Google